CHLAMYDIAL INFECTION
Clinical trials for CHLAMYDIAL INFECTION explained in plain language.
Never miss a new study
Get alerted when new CHLAMYDIAL INFECTION trials appear
Sign up with your email to follow new studies for CHLAMYDIAL INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Which antibiotic wins the battle against chlamydia in teens?
Disease control CompletedThis trial tests two approved antibiotics—azithromycin (a single dose) and doxycycline (twice daily for a week)—to see which is more effective at curing genital chlamydia in young people aged 12-21 living in youth correctional facilities. Participants provide urine samples over a…
Matched conditions: CHLAMYDIAL INFECTION
Phase: PHASE3 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Could a 3-Day antibiotic course beat the standard 7 days for chlamydia?
Disease control CompletedThis completed phase 4 trial tested whether taking doxycycline for 3 days works as well as the usual 7-day course for treating chlamydia. About 526 men and women with confirmed chlamydia took either a 3-day or 7-day regimen, with placebo pills used to keep the study blinded. Part…
Matched conditions: CHLAMYDIAL INFECTION
Phase: PHASE4 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC